Get the Stockscreener App
1.24
5.34%
-0.07
Pre-market:
1.25
0.01
+0.81%
MAIA Biotechnology Inc stock is traded at $1.24, with a volume of 493.66K.
It is down -5.34% in the last 24 hours and down -19.48% over the past month.
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.
See More
Previous Close:
$1.31
Open:
$1.34
24h Volume:
493.66K
Relative Volume:
0.89
Market Cap:
$40.91M
Revenue:
-
Net Income/Loss:
$-25.94M
P/E Ratio:
-0.8986
EPS:
-1.38
Net Cash Flow:
$-15.79M
1W Performance:
-13.29%
1M Performance:
-19.48%
6M Performance:
-47.01%
1Y Performance:
-55.40%
1-Day Range:
$1.22
$1.345
1-Week Range:
$1.22
$1.57
52-Week Range:
$1.22
$3.48
MAIA Biotechnology Inc Stock (MAIA) Company Profile
Name
MAIA Biotechnology Inc
Sector
Industry
Phone
312 416 8592
Address
444 West Lake Street, Suite 1700, Chicago
Compare MAIA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.24 | 43.22M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
MAIA Biotechnology Inc Stock (MAIA) Latest News
What MACD and RSI say about MAIA Biotechnology Inc.Portfolio Update Summary & Verified High Yield Trade Plans - newser.com
Real time breakdown of MAIA Biotechnology Inc. stock performance2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Why MAIA Biotechnology Inc. is moving todayJobs Report & Risk Controlled Swing Alerts - newser.com
Top chart patterns to watch in MAIA Biotechnology Inc.Market Risk Summary & Risk Managed Investment Strategies - newser.com
Is MAIA Biotechnology Inc. stock a safe haven assetQuarterly Profit Review & Safe Investment Capital Preservation Plans - newser.com
Analyzing drawdowns of MAIA Biotechnology Inc. with statistical toolsIndex Update & Consistent Growth Equity Picks - newser.com
Can swing trading help recover from MAIA Biotechnology Inc. lossesMarket Movement Recap & Long-Term Investment Growth Plans - newser.com
Will MAIA Biotechnology Inc. stock see PE expansionIndex Update & Weekly High Momentum Picks - newser.com
How high can MAIA Biotechnology Inc. stock goDip Buying & Free Fast Gain Swing Trade Alerts - newser.com
Is MAIA Biotechnology Inc. stock prepared for digital transition2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com
Reversal indicators forming on MAIA Biotechnology Inc. stockMarket Trend Summary & Detailed Earnings Play Alerts - newser.com
Does MAIA Biotechnology Inc. show high probability of rebound2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com
How strong is MAIA Biotechnology Inc. stock balance sheetJuly 2025 Trends & Intraday High Probability Alerts - newser.com
Is MAIA Biotechnology Inc. stock bottoming out2025 Short Interest & Daily Risk Controlled Trade Plans - newser.com
Predicting MAIA Biotechnology Inc. trend using moving averagesWeekly Stock Report & High Accuracy Trade Alerts - newser.com
Is MAIA Biotechnology Inc. stock among top earnings plays2025 Historical Comparison & Free Growth Oriented Trading Recommendations - newser.com
How MAIA Biotechnology Inc. stock behaves in tightening cycles2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
Is MAIA Biotechnology Inc a good long term investmentMarket Entry Points & Next-Level Stock Intelligence, Now Free - earlytimes.in
Published on: 2025-10-28 23:33:31 - newser.com
MAIA Biotechnology Inc Stock (MAIA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Cap:
|
Volume (24h):